Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion

Abstract Combined hepatocellular-cholangiocarcinoma (cHCC-CCA), an extremely rare and underinvestigated subtype of primary liver cancer in children, generally has a poor prognosis and greater aggressiveness. Histological diagnosis of cHCC-CCA is difficult because of its diverse components, including...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Guo-qian He, Qing Li, Xiao-yu Jing, Jian Li, Ju Gao, Xia Guo
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2024-12-01
Rangatū:	Molecular Cancer
Ngā marau:	Hepatoblastoma, Children, combined hepatocellular-cholangiocarcinoma Hepatocellular carcinoma Cholangiocarcinoma FGFR2
Urunga tuihono:	https://doi.org/10.1186/s12943-024-02190-w
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!